BIO-TECHNE TO PRESENT AT THE 43rd ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE

Company Overview - Bio-Techne Corporation is a global life sciences company providing innovative tools and bioactive reagents for research and clinical diagnostic communities [2] - The company's products assist in scientific investigations into biological processes, disease progression, drug discovery, and accurate clinical tests and diagnoses [2] - Bio-Techne has a portfolio of hundreds of thousands of products and generated approximately $1.2 billion in net sales in fiscal 2024 [2] - The company employs approximately 3,100 people worldwide [2] Upcoming Event - Kim Kelderman, President and CEO of Bio-Techne, will present at the 43rd Annual J.P. Morgan Healthcare Conference on January 14, 2025, at 10:30 a.m. PST [1] - A live webcast of the presentation will be available on Bio-Techne's Investor Relations website [1]